91
88
Growth Score
28 pts
Heat Score
87 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
4401644
Terasom develops exosome-based diagnostics, immunotherapy vaccines, and regenerative medicines for lung and other cancers.
About the Company
Terasom develops exosome-based biomedical solutions for cancer diagnosis and treatment. The company focuses on an exosome-based liquid biopsy platform that detects specific lung cancer biomarkers to enable rapid diagnosis of early and metastatic stages. It also develops immunotherapy vaccines that use bioengineered exosomes to help prevent solid
tumour formation and support treatment across different cancer stages by engaging the immune system. In addition, Terasom works on regenerative exosome-based medicines aimed at revitalising damaged lung tissue. Its research targets the tumour microenvironment and applies interdisciplinary methods to advance new anti-cancer therapies.
